Casdin Capital, LLC 13D/13G Filings for Verve Therapeutics, Inc. (VERV)

Casdin Capital, LLC 13D and 13G filings for Verve Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
9:27 pm
Sale		 2022-12-31 13G Verve Therapeutics, Inc.
VERV		 Casdin Capital, LLC 2,290,571
3.700%		 -847,596decrease
(-27.01%)		 Filing
2022-02-14
09:27 am
Purchase		 2021-12-31 13G Verve Therapeutics, Inc.
VERV		 Casdin Capital, LLC 3,138,167
6.500%		 100,000increase
(+3.29%)		 Filing
2021-06-23
11:38 am
Purchase		 2021-06-17 13G Verve Therapeutics, Inc.
VERV		 Casdin Capital, LLC 3,038,167
6.600%		 3,038,167increase
(New Position)		 Filing